INTRODUCTION
Our laboratory has been studying methicillin-resistant Staphylococcus aureus (MRSA) in an attempt to understand why there has been an epidemic spread of MRSA strains in Australian hospitals in recent years (Pavillard et al., 1982) . Genetic analysis of these epidemic strains of MRSA revealed the presence of a particular class of plasmids encoding gentamicin resistance (Grubb et al., 1983; Townsend et al., 1983a, 19848 and 1984~) . The most common plasmid, of mol. wt 18 x lo6, also codes for trimethoprim resistance. Initially, it was thought that this class of plasmid was primarily maintained by the MRSA for the gentamicin-resistance determinant. Subsequently, the transposable nature of this determinant was confirmed (Townsend et al., 1984c) and it now seems unlikely that gentamicin has been the selective agent for these plasmids (Grubb et al., 1983) . Consequently, several antiseptics were investigated as possible selective agents.
This class of plasmid was found to encode resistance to cetyltrimethyl-ammonium bromide and propamidine isethionate (Townsend et al., 1984~) . Although both these compounds are used in antiseptic preparations, it seemed unlikely that this is the reason for the spread of strains carrying such a resistance determinant. To characterise further the nature of resistance to these agents, various organic cationic compounds, including acriflavine and ethidium bromide, were examined. Resistance to acriflavine (Ericson, 1969) and ethidium bromide (Johnston and Dyke, 1969; Archer and Johnston, 1983; Foster, 1983; McDonnell et al., 1983) has been reported previously in S. aureus. The level of resistance to these compounds was compared in propamidinesensitive and -resistant strains that were isogenic except for the presence or absence of the propamidine-resistance determinant and other associated markers.
MATERIALS AND METHODS

Strains of S. aureus.
The majority of strains of S. aureus studied have been described previously (Townsend et al., 19836, 19843 and 1984c) Novick and' Bouanchaud, 197 1 Townsend et al, 19836, 1984c Townsend et al, 19836, 19846 Townsend et al, 1984c Townsend et al, 1984a Townsend et al, 1984c Townsend et al, 1984c Townsend et al, 19836, 1984c ...
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... ... Pi = propamidine isethionate, Tp = trimethopiim, Gm = gentamicin, Nm = neomycin, Pase = penicillinase production, Fa = fusidic acid, Rf = rifampicin, superscript R = resistance.
RESISTANCE TO NUCLEIC ACID-BINDING COMPOUNDS IN S. AUREUS 141
15 ml of Mueller-Hinton Agar (Gibco Diagnostics). Strains were grown overnight in Brain Heart Infusion Broth (Gibco), diluted 1 in 500 in 1 peptone water and then inoculated on to the test plates by the multipoint method. Plates were incubated overnight at 37°C and the lowest concentration of compound that prevented the appearance of visible growth was taken as the MIC.
For each strain of S. aweus, the MIC of the following compounds was determined: ethidium bromide, methylglyoxal bis(guanylhydrazone), spermine hydrochloride and spermidine tri-hydrochloride (Sigma); propamidine isethionate and amicarbalide isethionate (May and Baker); benzoflavin and coriphosphine 0 (K & K Laboratories Inc.); pyronin Y, acridine yellow and crystal violet (Gurr, Searle Diagnostic); imidocarb dipropionate (Wellcome Australia Ltd); acriflavine (BDH Chemicals Ltd); cetyltrimethyl-ammonium bromide (Ajax Chemicals); acridine orange and safranin 0 (Chroma-Gesellschaft Schmid and Co.); chlorhexidine digluconate (Imperial Chemical Industries).
RESULTS
All strains of S. aureus carrying a resistance determinant to propamidine isethionate were also found to have increased resistance to several other cationic agents (table 11). The level of resistance to these compounds was independent of other markers on the same plasmid. However, the MICs of these agents for strain WG3221, which carries the resistance determinant on the chromosome, were reduced by 2-to %fold in comparison with strains carrying plasmid-borne resistance.
The compounds exhibiting the greatest difference in MIC (up to a 128-fold increase) between resistant strains and their isogenic, sensitive derivatives were ethidium bromide, acriflavine, safranin 0, benzoflavin and propamidine isethionate (table 11). Other compounds with an appreciable difference in MTC were pyronin Y, acridine yellow and imidocarb dipropionate. The resistance determinant conferred only a small increase in resistance to crystal violet (gentian violet), cetyltrimethylammonium bromide, amicarbalide isethionate, and methylglyoxal bis(guany1hydra-zone). There was no significant difference between propamidine-resistant and -sensitive strains in their resistance to chlorhexidine digluconate, coriphosphine 0, acridine orange, spermine or spermidine.
DISCUSSION
Strains of S. aureus that were resistant to propamidine isethionate and cetyltrimethyl-ammonium bromide showed various degrees of cross-resistance to a broad range of cationic agents. An examination of the chemical structure of these compounds revealed several common features. Where the increase in MIC for a compound was more than 16-fold, the compound was symmetrical and contained two or more basic aromatic groups with terminal primary amine, tertiary amine, amidino or imidazole rings.
Despite the wide spectrum of compounds against which the resistance determinant was directed, relatively minor modifications in the chemical structure of the agents sometimes reduced significantly the degree of resistance. Thus, di-methyl substitution of one or both amine groups of acriflavine to form coriphosphine 0 or acridine orange respectively negated the effect of the resistance determinant. In fact, strains of S. aureus carrying the cationic-resistance determinant tended to be more sensitive than their isogenic derivatives to acridine orange.
Because of their basic nature, all the compounds whose resistance is coded for by * MIC values were calculated as described in Materials and methods and are expressed as pmol/L. the determinant bind to a variety of anionic compounds including nucleic acids, mast-cell heparin and mucopolysaccharides. Bis(guany1hydrazones) (Denny and Cain, 1979) , quaternary ammonium compounds (Scott, 1962) and diamidine compounds such as propamidine and amicarbalide (Anne et al., 1980) bind to nucleic acids, and the DNA-intercalating properties of ethidium bromide (Cain et al., 1978) and the acridines (Wolfe et al., 1972) have been well documented. This common property of binding to nucleic acids has prompted us to refer to the determinant encoding resistance to these compounds as the NAB (nucleic acid-binding compounds)-resistance determinant. The antibacterial action of human semen has been attributed, at least in part, to the naturally occurring polyamines, spermine and spermidine (Razin and Rozansky, 1957) and the inhibitory action of these compounds on gram-positive cocci has been well documented (Rozansky et al., 1954; Fair and Wehner, 1971; Bachrach, 1973) . The NAB-resistance determinant did not confer an increased resistance to spermine hydrochloride or spermidine tri-hydrochloride. In contrast, NAB-resistant strains of S. aureus tended to show an increased sensitivity towards spermine hydrochloride in comparison to their NAB-sensitive isogenic derivatives (table 11) .
Three representative isolates of MRSA were examined for their resistance to NAB agents. Strain WG1437, isolated from Royal Perth Hospital before 1973, is representative of the earlier strains of MRSA that lacked resistance to propamidine, whereas strains WG525 and WG588 were isolated after 1980 and carry a NAB-resistance determinant (Townsend et al., 1984b) . The NAB-resistance profile of strain WG1437 was very similar to that of the Oxford strain, NCTC 6571, and other sensitive recipient strains such as RN450 and WG1876 (table 11) . Loss of the NAB-resistance plasmid from strains WG525 and WG588 (becoming strains WG686 and WG935 respectively) decreased their NAB resistance to that of sensitive organisms (table 11) .
Regardless of the source of the NAB-resistance determinant, the relative degree of resistance conferred to each compound studied was always similar. The decrease in levels of resistance displayed by strain WG322 1, which carries chromosomal NAB-resistance, may reflect a gene dosage effect, because there may be more copies of the resistance determinant per cell when it is plasmid-borne than when it is located on the chromosome. The present results suggest that the NAB-resistance determinants present in the isolates of MRSA studied are similar and are distributed world-wide. They indicate that resistance to all the NAB compounds is conferred by the same determinant. Current studies will probably confirm this. Genetic determinants for resistance to acriflavine (Ericson, 1969) and ethidium bromide (Johnston and Dyke, 1969; Archer and Johnston, 1983; Foster, 1983; McDonnell et al., 1983) have been reported previously in S. aureus and they may be similar to the NAB-resistance determinant described here.
The use of agents such as acriflavine, propamidine, cetyltrimethyl-ammonium bromide and crystal violet in topical antiseptic creams may provide an explanation for the maintenance of the NAB-resistance determinant, but the current lack of widespread use of acriflavine and propamidine and the very small increase in resistance to cetyltrimethyl-ammonium bromide and crystal violet make this interpretation unlikely. We are now investigating several alternative possibilities that may indicate why this resistance determinant is carried by the MRSA strains currently being isolated in epidemic proportions in Australia (Pavillard et al., 1982) .
